All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.
Herpes Zoster (Shingles)
FREE ONE-MONTH ACCESS
Institutional (.edu or .org) Email Required
Register Now!
No institutional email? Start your 1-week free trial, now!

Herpes Zoster (Shingles)

Pathogenesis (VZV Reactivation)
  • Latent varicella-zoster virus (VZV) lies dormant in nerve root ganglion. Typically, there is very little, smoldering activity.
  • During VZV "reactivation", VZV replicates to a critical threshold and spreads within the dorsal root ganglion and tracks down the sensory nerves to spread into the skin in a dermatomal distribution.
Clinical Characteristics
  • Pain precedes rash by ~ 3 to 7 days.
  • Vesicles develop over several days in a dermatomal distribution (most commonly along a thoracic level) or in a cranial nerve distribution.
  • The most commonly affected cranial nerves are CN 5, the trigeminal nerve and CN 7, the facial nerve. CN 8, the vestibulocochlear nerve, runs in close proximity to CN 7 and so CN 8 is also often affected.
    • Ramsay Hunt Syndrome is the eponym used to described a syndrome that involves both CNs 7 and 8, with symptoms/signs of ipsilateral facial paralysis, otalgia (inner ear pain), vesicles in the auditory canal or auricle, and potentially vestibular symptoms (eg, nystagmus) or auditory symptoms (eg, tinnitus).
  • Patients are no longer contagious after 10 days of rash.
  • Postherpetic neuralgia is persistent neuralgia 90 days post rash.
Prevention (Vaccination)
  • Recombinant zoster vaccine (RZV) has been shown to be more effective than Zoster live vaccine (ZVL) but has more side effects. However, the side effects are typically transient (1 - 3 days), so it is generally recommended that when possible the recombinant zoster vaccine should be given.
  • VZV vaccination is loosely recommended in those 50+ years-old and strongly recommended in those 60+ years-old.
Treatment (Uncomplicated Shingles)
7 days of treatment of any of the following are typically recommended:
  • Valacyclovir 1000 mg PO three times daily
  • Famciclovir: 500 mg PO three times daily
  • Acyclovir: 800 mg PO five times daily
Complications
Numerous complications can occur from shingles including but not limited to:
  • Postherpetic neuralgia
  • Disseminated zoster
    • 3 or more contiguous dermatomes or any non-contiguous dermatomes.
    • Bilateral dermatomal distribution.
    • Visceral involvement
  • Herpes zoster ophthalmicus or Acute retinal necrosis
  • Ramsay Hunt syndrome
  • Meningoencephalitis, Myelitis, or Radiculitis (Guillain-Barre Syndrome)
References
Clinical Presentations and Outcome Studies of Cranial Nerve Involvement in Herpes Zoster Infection: A Retrospective Single-Center Analysis Herpes Zoster Rash